Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03242954 · ClinicalTrials.gov registry record · NA
Innovative Approaches for Minor Consent: Consent 2.0
A NA study of HIV, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 254
- Enrollment target
- 4
- Study locations
NCT03242954: Completed NA study of HIV, sponsored by Indiana University.
NCT03242954 is a NA study of HIV that has completed, run by Indiana University. The registered enrollment target is 254 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (42% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03242954, a NA study of HIV, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 254 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to examine how the consent process affects the acceptability of participation in biomedical HIV prevention trials, from the perspective of behaviorally high-risk minors and the parents of minor adolescents.
Primary Outcome
Comparing mean adolescent Willingness to Participate (WTP) scores across the three consent conditions and two trial types. WTP scores are based on the response to the question: "If offered the chance, how likely would you be to participate in the study?" Responses are collected using a Likert scale (definitely not participate, probably not participate, might or might not participate, probably participate, definitely participate) and converted to a numeric score with values ranging from 1 (defin
Conditions Studied
Interventions
- OTHER Autonomous minor consent
- OTHER Adult permission required
- OTHER Parental permission required
Study Locations (4)
Colorado
- Children's Hospital Colorado/Univ of Colorado SOM - Aurora
Florida
- University of South Florida - Tampa
Illinois
- University of Chicago - Chicago
Maryland
- Johns Hopkins University/SOM - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 254 participants |
| Start Date | 2017-11-07 |
| Est. Completion | 2019-09-15 |
| Phase | NA |
What the finished NCT03242954 record still lists
NCT03242954 is an interventional study that assigns participants to a tested intervention. The registered 254 participants enrollment target is mid-sized for trials with a published cap, below the 439-participant average among 303 other HIV trials with a reported enrollment target (42% lower).
The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 3 interventions - of which Autonomous minor consent is the first listed.
NCT03242954 reports a single indexed study location in Colorado, Florida, Illinois.
Frequently Asked Questions
What is clinical trial NCT03242954 about?
NCT03242954 is a clinical study titled "Innovative Approaches for Minor Consent: Consent 2.0". The purpose of this study is to examine how the consent process affects the acceptability of participation in biomedical HIV prevention trials, from the perspective of behaviorally high-risk minors and the parents of minor adolescents.
What is the current status of trial NCT03242954?
This trial is currently completed. It is a NA study. The enrollment target is 254 participants. The study started on 2017-11-07. Estimated completion is 2019-09-15.
What conditions does trial NCT03242954 study?
This clinical trial studies the following conditions: HIV.
What interventions are being tested in trial NCT03242954?
The interventions under investigation include: Autonomous minor consent (OTHER), Adult permission required (OTHER), Parental permission required (OTHER).
Who is sponsoring clinical trial NCT03242954?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03242954 being conducted?
This trial has 4 study locations across Colorado, Florida, Illinois, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03242954's enrollment target sits among peer trials
254 86th of 303 higher than 218 of 303 other HIV trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04390737 · 254 participants · Phase 1
Evaluate the Safety and Clinical Activity of HH2853
- NCT04677647 · 254 participants · NA
OurChild: A Health IT Solution to Reduce Minority Health Disparities
- NCT05503797 · 254 participants · Phase 2
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- NCT06167317 · 254 participants · Phase 1
Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI